Ganga Pharmaceuticals Q2 Results
- BSE: 539680
- NSE: -
- ISIN: INE615T01017
- Sector: Biotechnology & Drugs
BSE
12.00
0.00 (0.00%)
0.00 (0.00%)Volume0.00
Updated: Thu 12 Feb, 2026 | 16:00:02
NSE
This stock is not traded on NSE
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹1.37 Cr.(4.21%)
- Operating Profit₹-0.05 Cr.(-64.69%)
- Profit After Tax₹0.02 Cr.(3.06%)
- Operating Margin-3.52%(NA%)
Note: Comparison is on YoY basis
Quarterly - Ganga Pharmaceuticals Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 25 | - | QoQ Comp | Sep 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 1.41 | - | N/A | 1.30 | -2.27% |
| Depreciation/ Amortization | 0.03 | - | N/A | 0.03 | 5.88% |
| Operating Income | -0.05 | - | N/A | 0.02 | -64.69% |
| Net Income | 0.02 | - | N/A | 0.02 | 3.06% |
| Other Operating Expenses Total | 0.44 | - | N/A | 0.39 | -14.31% |
| Net Income Before Taxes | 0.03 | - | N/A | 0.02 | -50.16% |
| Total Revenue | 1.37 | - | N/A | 1.32 | 4.21% |
| Selling/ General/ Admin Expenses Total | 0.32 | - | N/A | 0.25 | 11.04% |
| Diluted Normalized EPS | 0.04 | - | N/A | 0.04 | -20.00% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.